Virtual Neuro-Navigation System for Personalized Community-Based TMS
Study Investigating a Treatment for Depression in Patients with Major Depressive Disorder (MDD)
Sponsor: Soterix Medical Inc. and National Institute of Mental Health
Enrolling: Male and Female Patients
Study Length: 2 Months
IRB Number: AAAU2047
U.S. Govt. ID: NCT04956081
Contact: Rashel Mejia: / rashel.mejia@nyspi.columbia.edu
Additional Study Information: Are you suffering from chronic depression? We are seeking participants for a depression treatment research study at Columbia University using Transcranial Magnetic Stimulation (TMS). This study develops a more accurate TMS to treat chronic depression. Participation includes clinical assessments and magnetic resonance imaging (MRI). You will receive 27 sessions of TMS treatment over up to 8 weeks. This study will test a novel form of neuronavigated transcranial magnetic stimulation (rTMS) which may achieve better results than conventional rTMS by using a specially processed MRI image to optimize targeting of brain regions thought to contribute to depression. Patients with treatment-resistant depression including those for whom conventional rTMS was not successful may be eligible to participate.
Investigator
Joshua Berman, MD, PhD
Do You Qualify?
Are you diagnosed with Major Depressive Disorder (MDD)? Yes No
Do you live in NYC / Can you comfortably travel to NYC for the duration of the study? Yes No
Are you currently pregnant or breastfeeding? Yes No
Can you commit to daily TMS treatment, 5-days a week? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Rashel Mejia
rashel.mejia@nyspi.columbia.edu